MedTrace Logo

Lidocaine Jelly for Pain Control During Mohs Surgery

NCT03595449 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 233

Last updated 2021-07-13

Study results available
· View outcomes & findings →

Summary

Does the use of lidocaine jelly during Mohs surgery on the nose decrease the total amount of lidocaine used during surgery.

Does patient satisfaction improve when lidocaine jelly is used during Mohs surgery of the nose?

Conditions

  • Pain
  • Satisfaction, Consumer

Interventions

DRUG

Lidocaine jelly

lidocaine 2% jelly applied during Mohs surgery

DRUG

Surgilube

surgilube (placebo) applied during Mohs surgery

Sponsors & Collaborators

Principal Investigators

  • Shari A Ochoa, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-13
Primary Completion
2020-08-31
Completion
2020-08-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03595449 on ClinicalTrials.gov